SilverCrest Metals
SILV
Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -29.72%200.66K | -60.78%257K | -58.19%259.32K | 3.07%6.99M | 883.54%5.43M | -59.87%285.52K | -65.24%655.34K | -82.92%620.23K | -58.69%6.78M | -76.77%551.72K |
Operating revenue | -29.72%200.66K | -60.78%257K | -58.19%259.32K | 3.07%6.99M | 883.54%5.43M | -59.87%285.52K | -65.24%655.34K | -82.92%620.23K | -58.69%6.78M | -76.77%551.72K |
Cost of revenue | 16.15%83.83K | -52.37%45.57K | 138.39%83.79K | 31.45%5.67M | 6,949.37%5.46M | -73.39%72.17K | -93.93%95.68K | -98.53%35.15K | -47.16%4.31M | -96.53%77.5K |
Gross profit | -45.24%116.83K | -62.22%211.43K | -70.00%175.53K | -46.48%1.32M | -107.84%-37.17K | -51.53%213.35K | 81.75%559.66K | -53.04%585.08K | -70.09%2.47M | 236.42%474.21K |
Operating expense | 11.25%3.75M | 27.77%6.1M | 54.28%5.77M | -54.60%26.49M | 271.69%14.61M | -48.42%3.37M | -70.03%4.77M | -88.29%3.74M | 53.01%58.34M | -79.91%3.93M |
Selling and administrative expenses | 30.44%2.54M | 41.02%4.77M | 92.12%4.49M | -60.57%20.8M | 430.06%13.13M | -61.46%1.95M | -76.89%3.38M | -92.36%2.33M | 55.87%52.74M | -86.36%2.48M |
-General and administrative expense | 30.44%2.54M | 41.02%4.77M | 92.12%4.49M | -60.57%20.8M | 430.06%13.13M | -61.46%1.95M | -76.89%3.38M | -92.36%2.33M | 55.87%52.74M | -86.36%2.48M |
Depreciation amortization depletion | -15.01%1.21M | -4.41%1.33M | -8.57%1.28M | 1.61%5.69M | 1.42%1.47M | -3.85%1.42M | 7.30%1.39M | 2.30%1.41M | 30.49%5.6M | 4.55%1.45M |
-Depreciation and amortization | -15.01%1.21M | -4.41%1.33M | -8.57%1.28M | 1.61%5.69M | 1.42%1.47M | -3.85%1.42M | 7.30%1.39M | 2.30%1.41M | 30.49%5.6M | 4.55%1.45M |
Operating profit | -15.08%-3.63M | -39.72%-5.89M | -77.33%-5.59M | 54.96%-25.17M | -323.78%-14.64M | 48.20%-3.15M | 73.02%-4.22M | 89.72%-3.16M | -87.01%-55.87M | 82.20%-3.46M |
Net non-operating interest income expense | 47.93%-126.75K | -196.08%-121.82K | -444,321.74%-102.22K | 50.82%-376.11K | 86.74%-91.52K | -55,676.26%-243.42K | 42.09%-41.14K | 99.42%-23 | 96.14%-764.84K | 93.41%-690.25K |
Non-operating interest expense | ---- | ---- | 444,321.74%102.22K | -50.82%376.11K | ---- | ---- | ---- | -99.42%23 | -96.14%764.84K | ---- |
Total other finance cost | -47.93%126.75K | 196.08%121.82K | ---- | ---- | ---- | 55,676.26%243.42K | -42.09%41.14K | ---- | ---- | ---- |
Other net income (expense) | -137,663.96%-4.28M | 10,925.56%43.99K | 10.52%-52.68K | 96.33%-136.43K | -133.27%-74.85K | 38.01%-3.11K | -99.84%399 | 98.59%-58.87K | 24.17%-3.72M | 106.92%225.01K |
Special income (charges) | ---4.3M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | --4.3M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 758.00%20.43K | 10,925.56%43.99K | 10.52%-52.68K | 96.33%-136.43K | -133.27%-74.85K | 38.01%-3.11K | -99.84%399 | 98.59%-58.87K | 24.17%-3.72M | 106.92%225.01K |
Income before tax | -136.25%-8.03M | -40.21%-5.97M | -78.90%-5.75M | 57.46%-25.68M | -277.73%-14.81M | 44.19%-3.4M | 72.45%-4.26M | 90.78%-3.21M | -10.60%-60.36M | 88.17%-3.92M |
Income tax | 12.81K | 4.15K | 4.15K | 156.81%60K | 156.81%60K | 0 | 0 | 0 | 101.40%23.36K | 101.40%23.36K |
Net income | -136.63%-8.05M | -40.31%-5.97M | -79.03%-5.75M | 57.37%-25.74M | -277.01%-14.87M | 44.19%-3.4M | 72.45%-4.26M | 90.79%-3.21M | -14.12%-60.38M | 87.47%-3.94M |
Net income continuous Operations | -136.63%-8.05M | -40.31%-5.97M | -79.03%-5.75M | 57.37%-25.74M | -277.01%-14.87M | 44.19%-3.4M | 72.45%-4.26M | 90.79%-3.21M | -14.12%-60.38M | 87.47%-3.94M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -136.63%-8.05M | -40.31%-5.97M | -79.03%-5.75M | 57.37%-25.74M | -277.01%-14.87M | 44.19%-3.4M | 72.45%-4.26M | 90.79%-3.21M | -14.12%-60.38M | 87.47%-3.94M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -136.63%-8.05M | -40.31%-5.97M | -79.03%-5.75M | 57.37%-25.74M | -277.01%-14.87M | 44.19%-3.4M | 72.45%-4.26M | 90.79%-3.21M | -14.12%-60.38M | 87.47%-3.94M |
Basic earnings per share | -9.42%-1.4724 | 11.98%-1.47 | -57.40%-2.0057 | 58.59%-9.9132 | -196.86%-5.1681 | 43.46%-1.3457 | 72.58%-1.67 | 90.77%-1.2743 | 41.32%-23.941 | 77.68%-1.741 |
Diluted earnings per share | -9.42%-1.4724 | 11.98%-1.47 | -57.40%-2.0057 | 58.59%-9.9132 | -196.86%-5.1681 | 43.46%-1.3457 | 72.58%-1.67 | 90.77%-1.2743 | 41.32%-23.941 | 77.68%-1.741 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |